Semaglutide as a possible therapy for healthy aging: Targeting the hallmarks of aging.

Gabriela Ueta Ortiz, Ellen Cristini de Freitas

Department of Health Sciences, Ribeirão Preto Medical School, University of São Paulo, USP, Ribeirão Preto, São Paulo, Brazil.Department of Health Sciences, Ribeirão Preto Medical School, University of São Paulo, USP, Ribeirão Preto, São Paulo, Brazil. · pubmed

Paper

Abstract

With an aging population, the investigation of therapies that promote healthy aging becomes increasingly urgent. Here we discuss how Semaglutide can be a potential therapy to contribute to this goal by targeting key hallmarks of aging, such as inflammation, oxidative stress and stem cell exhaustion.

The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.

Research summary

The paper discusses Semaglutide as a potential therapy targeting key hallmarks of aging, which aligns with the goal of promoting healthy aging and addressing root causes of aging rather than merely treating symptoms. However, the impact appears to be limited as it may not provide groundbreaking insights or novel mechanisms that significantly advance the field of longevity research.

Author of this paper? Send a correction.